Eli Lilly Files Six Lawsuits Against US Sellers Of Black-Market Retatrutide
LLY•Lilly targets black-market retatrutide sellers
Aug. 12 (Reuters) - Eli Lilly and Company (LLY.N):
- Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
- Eli Lilly files six lawsuits against U.S. sellers of black-market retatrutide
- Eli Lilly reports over 14,000 unlawful retatrutide listings in 100 countries
- Lilly is calling on entities that sellers use to conduct their illegal business, including social media and e-commerce platforms
Source text: ID:nPn107Xg7a
Further company coverage: LLY.N
